Dr. Marik talks about treating asymptomatic patients with a pharmaceutical, the role and value of testing asymptomatic people, and Dr. Kory discusses the potential risks and side effects of Paxlovid.
View the full webinar here: https://odysee.com/@FrontlineCovid19CriticalCareAlliance:c/Weekly_Webinar_3222:4
Formed by leading critical care specialists in March 2020, the Front Line COVID-19 Critical Care Alliance (FLCCC) has developed highly effective treatment protocols that aim to prevent and treat COVID-19 at all stages of the disease.
We are a 100% donor-supported 501(c)(3) non-profit organization — our work would not be possible without you.
Your gifts help us expand our reach and share the latest research available, for the health and well-being of all.
To donate online, click here: https://covid19criticalcare.com/network-support/support-our-work/
To follow FLCCC, click here: https://covid19criticalcare.com/follow-flccc-2/
To learn more about our protocols, click here: https://covid19criticalcare.com/covid-19-protocols/
To register for weekly webinars, click here: https://geni.us/FLCCC_Webinar_Register
To buy FLCCC gear, click here: https://supportflccc.store/covidhealthpaul marikpaxlovidpierre kory